Advertisement

Meningiomas pp 31-43 | Cite as

Pathology of Meningiomas

  • Richard A. Prayson

The vast majority of meningiomas arise in the meninges from arachnoidal cap cells that are normally present in small nests. Harvey Cushing first introduced the term meningioma in 1922 to designate a group of tumors, which arose from the meninges of the brain and spinal cord [1]. Previous to Cushing, these tumors had been referred to by a variety of designations, including angioendothelioma, arachnoidal fibroblastoma, dural endothelioma, dural sarcoma, endotheliosis of the meninges, meningeal fibroblastoma, meningoblastoma, mesothelioma of the meninges, sarcoma of the dura, and fungus of the dura mater. In 1922, Oberling was one of the first to divide meningiomas into subtypes [2]. This classification was based on the concept of cell structure of the meninges and included three different groups. A few years later, Roussy and Cornil developed a similar three-group classification based on the cytologic structure of these neoplasms [3]. In 1930, del Rio Hortega devised a classification for meningiomas, which was based on structural and architectural features of the tumor [4]. In the following year, the classification began to expand with the recognition of the phenotypic variability of these tumors.

Keywords

Intracranial Meningioma Psammoma Body Atypical Meningioma Malignant Meningioma Clear Cell Meningioma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cushing H. The meningiomas (dural endotheliomas): Their source and favoured seats of origin. Brain 1922; 45:282–316.CrossRefGoogle Scholar
  2. 2.
    Oberling C. Les tumeurs des méninges. Bull Assoc Franc l'Etude Cancer 1922; 11:365–394.Google Scholar
  3. 3.
    Roussy G, Cornil L. Les tumeurs méningées. Ann d'Anat Path 1925; 2:63–79.Google Scholar
  4. 4.
    del Río Hortega P. Para el mejor conocimiento histológico de los meningoexotheliomas. Arch Españ Oncol. 1930; 1:477–570.Google Scholar
  5. 5.
    Bailey P, Bucy PC. The origin and nature of meningothelial tumors. Am J Cancer 1931; 15:15–54.Google Scholar
  6. 6.
    Cushing H, Eisenhardt L. Meningiomas: Their Classification, Regional Behavior, Life History and Surgical End Results. Charles C Thomas, Springfield, IL, 1938Google Scholar
  7. 7.
    Kernohan JW, Sayre GP. Tumors of the Central Nervous System. Armed Forces Institute of Pathology Fascicle, Washington, DC, 1952, pp. 97–117.Google Scholar
  8. 8.
    Zülch KJ. Histological Typing of Tumours of the Central Nervous System. World Health Organization, Geneva, 1979.Google Scholar
  9. 9.
    Kepes JJ. Meningiomas. Biology, Pathology and Differential Diagnosis. Masson Publishing, New York, 1982.Google Scholar
  10. 10.
    Louis DN, Scheithauer BW, Budka H, et al. Meningiomas. In: Tumours of the Nervous System (Kleihues P, Cavenee WK, eds.). IARC Press, Lyon, 2000, pp. 176–184.Google Scholar
  11. 11.
    Criscuolo GR, Symon L. Intraventricular meningioma. A review of 10 cases of the National Hospital, Queen Square (1974–1985) with reference to the literature. Acta Neurochirur-gica 1986; 83:83–91.CrossRefGoogle Scholar
  12. 12.
    Courville CB. Notes on the pathology of cranial tumors; hyper-ostoses-primary, secondary and neoplastic. Bull Los Angeles Neurol Soc 1947; 12:6–37.PubMedGoogle Scholar
  13. 13.
    Wall AE. Meningiomas within the lateral ventricle. J Neurol Neurosurg Psychiat 1954; 17:91–103.CrossRefPubMedGoogle Scholar
  14. 14.
    Dunn J Jr, Kernohan JW. Observations on the origin of menin-gioma from the choroid plexus of the lateral ventricle. Proc Staff Meetings Mayo Clin 1956; 31:25–30.Google Scholar
  15. 15.
    Bruner JM, Tien RD, Enterline DS. Tumors of the meninges and related tissues. In: Russell and Rubinsteins Pathology of Tumors of the Nervous System (Bigner DD, McLendon RE, Bruner JM, eds.). Arnold Press, London, 1998, pp. 69–139.Google Scholar
  16. 16.
    Helle TL, Conley FK. Haemorrhage associated with meningi-oma: a case report and review of the literature. J Neurol Neuro-surg Psychiat 1980; 43:725–729.CrossRefGoogle Scholar
  17. 17.
    Kleinman GM, Liszczak T, Tarlov E, et al. Microcystic variant of meningioma. A light microscopic and ultrastructural study. Am J Surg Pathol 1980; 4:383–389.PubMedGoogle Scholar
  18. 18.
    Michard J, Gagné F. Microcystic meningioma. Clinicopathologic report of eight cases. Arch Pathol Lab Med 1983; 107:75–80.Google Scholar
  19. 19.
    Kepes J. The fine structure of hyaline inclusions (pseudopsam-moma bodies) in meningiomas. J Neuropathol Exp Neurol 1975; 34:282–289.CrossRefPubMedGoogle Scholar
  20. 20.
    Alguacil-Garcia A. Pettigrew NM, Sima AAF. Secretory menin-gioma. A distinct subtype of meningioma. Am J Surg Pathol 1986; 10:102–111.CrossRefPubMedGoogle Scholar
  21. 21.
    Kubota T, Hirano A, Yamamoto S. The fine structure of hyaline inclusions in meningioma. J Neuropathol Exp Neurol 1982; 41:81–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Louis DN, Hamilton AJ, Sobel RA, et al. Pseudopsammomatous meningioma with elevated serum carcinoembryonic antigen: a true secretory meningioma. Case report. J Neurosurg 1991; 74:129–132.Google Scholar
  23. 23.
    Buhl R, Huga H-H, Mihajlovic HM. Secretory meningiomas: Clinical and immunohistochemical observations. Neurosurgery 2001; 48:297–302.CrossRefPubMedGoogle Scholar
  24. 24.
    Philippon J, Foncin JF, Grob R, et al. Cerebral edema associated with meningiomas: possible role of a secretory-excretory phenomenon. Neurosurgery 1984; 14:295–301.CrossRefPubMedGoogle Scholar
  25. 25.
    Banerjee AK, Blackwood W. A subfrontal tumour with the features of plasmocytoma and meningioma. Acta Neuropathol1971;18:84–88.CrossRefPubMedGoogle Scholar
  26. 26.
    Horten BC, Urich H, Stefoski D. Meningiomas with conspicuous plasma cell-lymphocytic components. A report of five cases. Cancer 1979; 43:258–264.Google Scholar
  27. 27.
    Stam FC, van Alphen HAM, Boorsma DM. Meningioma with conspicuous plasma cell components. A histopathological and immu-nohistochemical study. Acta Neuropathol 1980; 49:241–243.CrossRefPubMedGoogle Scholar
  28. 28.
    Dahmen HG. Studies on mucous substances in myxomatous meningiomas. Acta Neuropathol 1979; 48:235–237.CrossRefPubMedGoogle Scholar
  29. 29.
    Kepes JJ. Lipidized meningothelial tumor cells in “xanthoma-tous” meningioma express macrophage antigen. J Neuropathol Exp Neurol 1994; 53:384–388.CrossRefPubMedGoogle Scholar
  30. 30.
    Le Roux P, Hope A, Lofton S, et al. Lipomatous meningioma — an uncommon tumor with distinct radiographic findings. Surg Neurol 1989; 32:360–365.CrossRefGoogle Scholar
  31. 31.
    Salibi SS, Nauta HJ, Brem H, Epstein JI, Cho KR. Lipomeningioma: report of three cases and review of the literature. Neurosurgery 1989; 25:122–126.CrossRefPubMedGoogle Scholar
  32. 32.
    Lattes R, Bigotti G. Lipoblastic meningioma: ‘Vacuolated menin-gioma.’ Hum Pathol 1991;22:164–171.CrossRefPubMedGoogle Scholar
  33. 33.
    Friede RL, Yasargil MG. Suprasellar neoplasm with a granular cell component. J Neuropathol Exp Neurol 1977; 36:769–782.CrossRefPubMedGoogle Scholar
  34. 34.
    Müller W, Dahmen HG. Iron-induced atypical meningioma cells? Acta Neuropathologica 1979;48:231–234.CrossRefPubMedGoogle Scholar
  35. 35.
    Kawasaki K, Takahashi H, Kaneko H, et al. Novel eosinophilic intractyoplasmic inclusions in a meningioma. Cancer 1993; 72:2675–2679.CrossRefPubMedGoogle Scholar
  36. 36.
    Yamada S, Kawai R, Sano T, et al. Intracytoplasmic granulo-filamentous inclusion bodies in a meningioma. Immunohisto-chemical and ultrastructural studies. Arch Pathol Lab Med 1994; 118:849–851.PubMedGoogle Scholar
  37. 37.
    Rim NR, Im S-H, Chung CK, et al. Sclerosing meningioma: immunohistochemical analysis of five cases. Neuropathol Appl Neurobiol 2004; 30:126–135.CrossRefGoogle Scholar
  38. 38.
    Roncaroli F, Riccioni L, Cerati M, et al. Oncocytic meningioma. Am J Surg Pathol 1997; 21:375–382.CrossRefPubMedGoogle Scholar
  39. 39.
    Zorludemir S, Scheithauer BW, Hirose T, et al. Clear cell menin-gioma: a clinicopathologic study of a potentially aggressive variant of meningioma. Am J Surg Pathol 1995; 19:493–505.PubMedGoogle Scholar
  40. 40.
    Holtzman RN, Jormark SC. Nondural-based lumbar clear cell meningioma. Case report. J Neurosurg 1996; 84:264–266.Google Scholar
  41. 41.
    Couce ME, Aker FV, Scheithauer BW. Chordoid meningioma. A clinicopathologic study of 42 cases. Am J Surg Pathol 2000; 24:899–905.CrossRefPubMedGoogle Scholar
  42. 42.
    Kepes JJ, Chen WY, Connors MH, et al. “Chordoid” meningeal tumours in young individuals with peritumoural lymphoplas-macellular infiltrates causing systemic manifestations of the Castleman syndrome. A report of seven cases. Cancer 1988; 62:391–406.Google Scholar
  43. 43.
    Zuppan CW, Liwnicz BH, Weeks DA. Meningioma with chordoid features. Ultrastruct Pathol 1994; 18:29–32.CrossRefPubMedGoogle Scholar
  44. 44.
    de la Monte SM, Flickinger J, Linggood RM. Histopathologic features predicting recurrence of meningiomas following subtotal resection. Am J Surg Pathol 1986; 10:836–843.CrossRefPubMedGoogle Scholar
  45. 45.
    Deprez RHL, Riegman PH, von Drunen E, et al. Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas. J Neuropathol Exp Neurol 1995; 54:224–235.CrossRefGoogle Scholar
  46. 46.
    Jôôkskelôinen J. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 1986; 26:461–469.Google Scholar
  47. 47.
    Mahmood A, Caccamo DV, Tomecek FJ, et al. Atypical and malignant meningiomas: a clinicopathological review. Neurosur-gery 1993; 33:955–963.Google Scholar
  48. 48.
    Maier H, Ofner D, Hittmair A, et al. Classic, atypical, and anaplas-tic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 1992; 77:616–623.CrossRefPubMedGoogle Scholar
  49. 49.
    Miller DC. Predicting recurrence of intracranial meningiomas. A multivariate clinicopathologic model: interim report of the New York University Medical Center Meningioma Project. Neurosurg Clin North Am 1994; 5:193–200.Google Scholar
  50. 50.
    Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM. Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 1997; 21:1455–1465.CrossRefPubMedGoogle Scholar
  51. 51.
    Skullerud K, Löken AC. The prognosis in meningiomas. Acta Neuropathol (Berl) 1974; 29:337–344.CrossRefGoogle Scholar
  52. 52.
    Ng H-K, Poon W-S, Goh K, et al. Histopathology of post-embolized meningioma. Am J Surg Pathol 1996; 20:1224–1230.CrossRefPubMedGoogle Scholar
  53. 53.
    Ludwin SK, Rubinstein LJ, Russell DS. Papillary meningio-mas: a malignant variant of meningioma. Cancer 1975; 36: 1363–1373.CrossRefPubMedGoogle Scholar
  54. 54.
    Pasquier B, Gasnier F, Pasquier D, et al. Papillary meningioma. Clinicopathologic study of seven cases and review of the literature. Cancer 1986; 58:299–305.Google Scholar
  55. 55.
    Kepes JJ, Moral LA, Wilkinson SB, et al. Rhabdoid transformation of tumor cells in meningiomas: a histologic indication of increased proliferative activity. Report of four cases. Am J Surg Pathol 1998; 22:231–238.Google Scholar
  56. 56.
    Perry A, Stafford SL, Scheithauer BW, et al. “Rhabdoid” menin-gioma: An aggressive variant. J Neuropathol Exp Neurol 1998; 57:488.CrossRefGoogle Scholar
  57. 57.
    Prayson RA. Malignant meningioma. A clinicopathologic study of 23 patients including MIB1 and p53 immunohistochemistry. Am J Clin Pathol 1996; 105:719–726.PubMedGoogle Scholar
  58. 58.
    Perry A, Scheithauer BW, Stafford SL, et al. “Malignancy” in meningiomas. A clinicopathologic study of 116 patients, with grading implications. Cancer 1999; 85:2046–2056.PubMedGoogle Scholar
  59. 59.
    Miller DC, Ojemann RG, Proppe KH, et al. Benign metastasizing meningioma. J Neurosurg 1985; 62:763–766.CrossRefPubMedGoogle Scholar
  60. 60.
    Stoller JK, Kavuru M, Mehta AC, et al. Intracranial meningioma metastatic to the lung. Cleve Clin J Med 1987; 56:521–527.Google Scholar
  61. 61.
    Napolitano L, Kyle R, Fisher ER. Ultrastructure of meningiomas and their deviation and nature of their cellular components. Cancer 1963; 17:233–241.CrossRefGoogle Scholar
  62. 62.
    Humeau C, Vic P, Sentein P, et al. The fine structure of meningio-mas: An attempted classification. Virchows Arch A Pathological Anat Histol 1979; 382:201–216.CrossRefGoogle Scholar
  63. 63.
    Copeland DD, Bell SW, Shelburne JD. Hemidesmosome-like intercellular specializations in human meningiomas. Cancer 1978; 41:2242–2249.CrossRefPubMedGoogle Scholar
  64. 64.
    Márquez H, Díaz-Flores L, Caballero T, et al. Histogenesis of hemidesmosome-like intercellular specializations in meningi-oma. Morfología Normal y Patológica 1979; B3:33–41.Google Scholar
  65. 65.
    Goldman JE, Horoupian DS, Johnson AB. Granulofilamentous inclusions in a meningioma. Cancer 1980; 46:156–161.CrossRefPubMedGoogle Scholar
  66. 66.
    Robertson DM. Electron microscopic studies of nuclear inclusions in meningiomas. Am J Pathol 1964; 45:835–848.PubMedGoogle Scholar
  67. 67.
    Rajaram V, Brat DJ, Perry A. Anaplastic meningioma versus meningeal hemangiopericytoma: Immunohistochemical and genetic markers. Hum Pathol 2004; 35:1413–1418.CrossRefPubMedGoogle Scholar
  68. 68.
    Carroll RS, Zhang J, Dashner K, et al. Androgen receptor expression in meningiomas. J Neurosurg 1995; 82:453–460.CrossRefPubMedGoogle Scholar
  69. 69.
    Khalid H. Immunohistochemical study of estrogen receptor-related antigen, progesterone and estrogen receptors in human intracranial meningiomas. Cancer 1994; 74:679–685.CrossRefPubMedGoogle Scholar
  70. 70.
    Mehta D, Khatib R, Patel S. Carcinoma of the breast and meningi-oma. Association and management. Cancer 1983; 51:1937–1940.Google Scholar
  71. 71.
    Abramovich CM, Prayson RA. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: A study of 90 tumors. Hum Pathol 1998; 29:1420–1427.CrossRefPubMedGoogle Scholar
  72. 72.
    Hsu DW, Pardo FS, Efird JT, et al. Prognostic significance of proliferative indices in meningiomas. J Neuropathol Exp Neurol 1994; 53:247–255.CrossRefPubMedGoogle Scholar
  73. 73.
    Iwaki T, Takeshita I, Fukui M, et al. Cell kinetics of the malignant evolution of meningothelial meningiomas. Acta Neuro-pathol 1987; 74:243–247.CrossRefGoogle Scholar
  74. 74.
    Jääkskeläinen J, Haltia M, Laasonen E, et al. The growth rate of intracranial meningiomas and its relationship to histology: An analysis of 43 patients. Surg Neurol 1985; 24:165–172.CrossRefGoogle Scholar
  75. 75.
    Lanzafame S, Torrisi A, Barbagallo G, et al. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningio-mas with a 6 year mean follow-up. Pathol Res Pract 2000; 196:483–488.PubMedGoogle Scholar
  76. 76.
    Lee KS, Hoshino T, Rodriguez LA, et al. Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence. Acta Neuropathol 1990; 80:311–317.CrossRefPubMedGoogle Scholar
  77. 77.
    Ohta M, Iwaki T, Kitamoto T, et al. MIB1 staining index and scoring of histologic features in meningioma: Indicators for the prediction of biologic potential and postoperative management. Cancer 1994; 74:3176–3189.CrossRefPubMedGoogle Scholar
  78. 78.
    Salmon I, Kiss R, Levivier M, et al. Characterization of nuclear DNA content, proliferation index, and nuclear size in a series of 181 meningiomas, including benign primary, recurrent, and malignant tumors. Am J Surg Pathol 1993; 17:239–247.CrossRefPubMedGoogle Scholar
  79. 79.
    Spaar FW, Ahyai A, Blech M. DNA-fluorescence cytometry and prognosis (grading) of meningiomas. A study of 104 surgically removed tumors. Neurosurg Rev 1987; 10:35–39.CrossRefPubMedGoogle Scholar
  80. 80.
    Zimmer C, Gottschalk J, Cervos-Navarro J, et al. Proliferating cell nuclear antigen (PCNA) in atypical and malignant meningio-mas. Path Res Pract 1992; 188:951–958.PubMedGoogle Scholar
  81. 81.
    Perry A, Lusis EA, Gutmann DH. Meningothelial hyperplasia: A detailed clinicopathologic, immunohistochemical and genetic study of 11 cases. Brain Pathol 2005; 15:109–115.PubMedGoogle Scholar
  82. 82.
    Halper J, Scheithauer BW, Okazaki H, et al. Meningio-angiomatosis: A report of six cases with special reference to the occurrence of neu-rofibrillary tangles. J Neuropath Exp Neurol 1986; 45:426–446.CrossRefPubMedGoogle Scholar
  83. 83.
    Prayson RA. Meningioangiomatosis. A clinicopathologic study including MIB1 immunoreactivity. Arch Pathol Labl Med 1995; 119:1061–1064.Google Scholar
  84. 84.
    Wiebe S, Munoz DG, Smith S, et al. Meningioangiomatosis. A comprehensive analysis of clinical and laboratory features. Brain 1999; 122:709–726.CrossRefPubMedGoogle Scholar
  85. 85.
    Sakaki S, Nakagawa K, Nakamura K, et al. Meningioangiomato-sis not associated with von Recklinghausen's disease. Neurosur-gery 1987; 20:797–801.CrossRefGoogle Scholar
  86. 86.
    Stemmer-Rachamimov AO, Horgan MA, Taratuto AL, et al. Meningioangiomatosis is associated with neurofibromatosis 2 but not with somatic alterations of the NF2 gene. J Neuropath Exp Neurol 1997; 56:485–489.CrossRefPubMedGoogle Scholar
  87. 87.
    Bassoe P, Nuzum F. Report of a case of central and peripheral neurofibromatosis. J Nerv Ment Dis 1915; 42:785–796.CrossRefGoogle Scholar
  88. 88.
    Liu Y, Sturgis CD, Bunker M, et al. Expression of cytokeratin by malignant meningiomas: diagnostic pitfall of cytokeratin to separate malignant meningiomas from metastatic carcinoma. Mod Pathol 2004; 17:1129–1133.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2009

Authors and Affiliations

  • Richard A. Prayson
    • 1
  1. 1.Department of NeuropathologyCleveland ClinicClevelandUSA

Personalised recommendations